Summary
The second messenger systems coupled to phosphoinositide turnover, diacylglycerol (DG)-protein kinase C (PKC) and inositol 1,4,5-trisphosphate (IP3)-Ca2+ systems, were studied in the striatum of postmortem brains from 20 patients with Parkinson’s disease (PD) (Yahr III, IV and V), using 3H-4β phorbol 12,13-dibutyrate (3H-PDBu) and 3H-IP3 as the respective ligands. In the PD striatum, the specific bindings for 3H-PDBu and 3H-IP3 were not altered when all the patients without dementia, Yahr (III + IV) patients or Yahr V patients, without dementia were compared with control subjects. However, they were significantly decreased in the Yahr V patients with dementia (PDD) by 38% and 78%, respectively. These results suggest that the second messenger sites coupled to the phosphoinositide system are not concentrated in the nigrostriatal dopaminergic neurons and that striatal pathophysiology of PDD is different from that of PD without dementia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birkmayer W, Riederer P (1985) Die Parkinson-Krankheit. Biochemie, Klinik, Therapie, 2. Aufl. Springer, Wien New York
De La Monte SM, Wells SE, Hedley-Whyte ET, Growdon JH (1989) Neuropathological distinction between Parkinson’s dementia and Parkinson’s plus Alzheimer’s disease. Ann Neurol 26: 309–320
Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson’s disease: a neuropathological study of 32 cases. Acta Neuropathol (Berl) 64: 43–52
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427–442
Kitamura N, Hashimoto T, Nishino N, Tanaka C (1989) Inositol 1,4,5-trisphosphate binding sites in the brain: regional distribution, characterization, and alterations in brain of patients with Parkinson’s disease. J Mol Neurosci 1: 181–187
Nishino N, Kitamura N, Nakai T, Hashimoto T, Tanaka C (1989) Phorbol ester binding sites in human brain: characterization, regional distribution, age-correlation, and alterations in Parkinson’s disease. J Mol Neurosci 1: 19–26
Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665
Worley PF, Baraban JM, Snyder SH (1986) Heterogenous localization of protein kinase C in rat brain: autoradiographic analysis of phorbol ester receptor binding. J Neurosci 6: 199–207
Yoshihara C, Saito N, Taniyama K, Tanaka C (1991) Differential localization of four subspecies of protein kinase C in the rat striatum and substantia nigra. J Neurosci (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this paper
Cite this paper
Nishino, N., Kitamura, N., Hashimoto, T., Komure, O., Tanaka, C. (1991). Second messengers in Parkinson’s disease. In: Nagatsu, T., Narabayashi, H., Yoshida, M. (eds) Parkinson’s Disease. From Clinical Aspects to Molecular Basis. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9146-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9146-0_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82272-2
Online ISBN: 978-3-7091-9146-0
eBook Packages: Springer Book Archive